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doi:10.1016/j.ejvs.2010.11.017Abstract Aim: Monocytes play a significant role in neovascularisation. The stimuli that
differentiate monocytes along a pro-angio-/arteriogenic-supporting pathway are currently
unclear. We investigated whether pre-stimulation of human monocytes with soluble T-cell-
derived factors improves revascularisation in murine hind limb ischaemia as a new option
for therapeutic angio- and arteriogenesis.
Design: Human monocytes were cultured with or without soluble T-cell-derived factors. Unsti-
mulated and pre-stimulated monocytes were transfused after induction of hind limb ischaemia
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Pre-stimulated Monocytes Promote Revascularisation 419Methods: Blood flow was measured with laser Doppler perfusion imaging. Collaterals were vi-
sualised by immunohistochemistry and angiography. Monocytes were characterised by flowcy-
tometry and Bio-Plex assays.
Results: Transfusion of T-cell-pre-stimulated monocytes significantly improved blood flow
recovery after hind limb ischaemia and increased collateral size and collateral and capillary
number in the post-ischaemic paw. Pre-stimulated monocytes produced a wide variety of
factors that support neovascularisation such as platelet-derived growth factor-BB, vascular-
endothelial growth factor, interleukin-4 and tumour necrosis factor-a. Few transfused human
cells were detected in the muscle tissue, suggesting that paracrine rather than direct effects
appear responsible for the enhanced recovery of blood flow observed.
Conclusion: These results show a beneficial role for T-cell-pre-stimulated monocytes in neo-
vascularisation, rendering the monocyte a potential candidate for regenerative cell therapy
that promotes revascularisation in peripheral arterial disease patients.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Collateral artery formation (arteriogenesis) may prevent
tissue damage caused by arterial stenosis or occlusion, and
is crucially important to limit the consequences of periph-
eral arterial disease (PAD). Despite improvements of
vascular and endovascular techniques, major amputation is
still described in one-third of patients with critical limb
ischaemia, underscoring the urgent need for new thera-
peutic alternatives.1
Cell therapy is a promising novel therapeutic approach
for the treatment of patients with PAD. Selection of the
most efficient cell type for therapeutic purposes is
a central issue. Much attention has been given to the use of
endothelial progenitor cells (EPCs) that may augment
revascularisation by direct incorporation into the vessel
wall. Transfusion of EPCs isolated from circulating mono-
nuclear cells or the increase of circulating EPC numbers via
bone marrow (BM) mobilisation have been described to
promote neovascularisation in different animal models.2,3
However, outcomes of clinical studies in which BM-
derived cells (including EPCs) were transplanted into
ischaemic limbs of patients showed only minor
improvements.4e8 Moreover, the controversy about the
nature of human blood EPC complicated the isolation
procedure and, therefore, the development of a cellular
therapy.
The monocyte was highlighted as an alternative candi-
date for cell therapy that may facilitate vascular regener-
ation. Monocytes are pluripotent progenitor cells that,
depending on the stimulus encountered, may differentiate
into immune effectors such as macrophages or dendritic
cells (DCs). Notably, a still growing number of studies
additionally emphasises the involvement of the monocyte
or its mature progeny in angio- and arteriogenic processes.
The beneficial effects of monocyte transfusion were
underscored by several recent studies. Herold et al.9
demonstrated increased blood flow recovery after liga-
tion-induced ischaemia by transfusion of autologous
monocytes that were engineered by adenoviral trans-
duction to express granulocyte/macrophage-colony-stimu-
lating factor (GM-CSF), possibly by stimulating the
mobilisation of EPCs from the BM. Interestingly transfusion
of untransduced autologous monocytes stimulated ex vivo
with GM-CSF was ineffective. The importance of a stimulus
to mature monocytes along a certain pathway was
emphasised by a study of Urbich et al.10 Here, humanblood-derived mononuclear cells, CD14 or CD14þ-mono-
cyte-enriched populations that were stimulated in endo-
thelial medium with vascular-endothelial growth factor
(VEGF) to generate EPCs improved blood flow recovery in
a hind limb ischaemia model, whereas CD14- or CD14þ-
populations that were not stimulated before infusion did
not.
Besides monocytes, T-lymphocytes play an eminent role
in adult vascular repair as was exemplified by the hampered
blood flow recovery and reduced collateral density upon
hind limb ischaemia in various murine models that lack
CD4þ-T-helper lymphocytes.11,12 Moreover, significantly
lower numbers of monocytes/macrophages accumulated in
the ischaemic muscles of CD4þ-deficient mice,11 suggesting
that T-cell/monocyte interactions are involved in arterio-
genesis. We previously reported that co-culture of mono-
cytes with CD4þ-T-cells was indispensable for the formation
of colony-forming-unit (CFU)-Hill colonies.13 CFUeHill
colonies are correlated to vascular reactivity and although
they were initially thought to represent colony growth of
EPCs,14 it is now widely accepted that these colonies are of
haematopoietic origin.15,16 Instead of EPC-derived colony
growth, this in vitro culture actually represents the effi-
ciency of cluster formation between autologous T-lympho-
cytes and naı¨ve CD14þ-monocytes. Enhanced cluster
formation was observed upon prior activation of CD4þ-
T-cells, and replacement of T-cells by the addition of
activated CD4þ-T-cell-derived soluble factors similarly
stimulated cluster formation.13
The aim of this study was to further investigate the
phenotype of the T-cell-pre-stimulated monocytes and to
examine whether pre-stimulation of naı¨ve human CD14þ-
monocytes with T-cell-derived soluble factors promotes
their capacity to improve vascular regeneration in a murine
hind limb ischaemia model for PAD.
Materials and Methods
Isolation and culture of human primary cells
Human CD14þ-monocytes or CD4þ-T-cells-enriched fresh
apheresis mononuclear cell preparations from healthy
donors were obtained at Sanquin Bloodbank NW Amsterdam
after informed consent and with the approval of the
420 A.A. Hellingman et al.Medical Ethical Committee of the Academic Medical
Center, Amsterdam, the Netherlands. T-cell and monocyte
isolation as well as CD4þ-T-cell activation were performed
as described previously.13 Distinct CD14þ/CD16, CD14þ/
CD16þ and CD14lo/CD16þ monocyte subsets were sorted
with a MoFlow cell sorter (Beckman Coulter).
Total CD14þ-monocytes or monocyte subsets were
cultured for 48 h in fibronectin-coated plates (BD Biosci-
ences) at a density of 1 106 cellsml1 in Endocultmedium
(Stem Cell Technologies) or stimulated with a 4:1 mixture of
Endocult medium and pooled T-cell-conditioned medium
(TCCM) from three to four individual donors. Formacrophage
or DC cultures, CD14þ-monocytes were similarly cultured for
48 h in Endocult medium supplemented with 10 ng ml1
macrophage-colony stimulating factor (M-CSF) (Peprotech)
or GM-CSF (1000 U ml1) þ interleukin (IL)-4 (2000 U ml1)
(Invitrogen), respectively.
For transfusion in vivo, loosely adherent cells were har-
vested after 48 h by pipetting,washed twicewith phosphate-
buffered saline (PBS) and infused into the mice within 1 h.
Monocyte-conditioned medium was prepared by removal
of culture media after 48 h, followed by three washes with
PBS and addition of fresh endocult medium that was
subsequently harvested after 24, 48 or 72 h. The production
of secreted proteins was determined using a Bio-Plex
cytokine-assay (Bio-Rad).
Expression analysis of cell surface proteins by
flowcytometry
Expression of leucocyte surface molecules was determined
using directly conjugated antibodies that were added to the
cells after 15 min of pre-incubation with 10 mg ml1 purified
human immunoglobulin G (IgG) to block non-specific
binding. Non-specific isotype-matched antibodies were
used as negative controls. Mean fluorescence intensity
(MFI) of the labelled cells was measured using a flowcy-
tometer (FACScan; BectoneDickinson) and analysed with
Cellquest software (BectoneDickinson) and WinMDI.
Animals
To avoid immune reactivity against transfused human cells,
immunodeficient nude C57Bl6 (no functional T- and B-
lymphocytes) and non-obese diabetic-severe combined
immunodeficiency interleukin receptor (NOD-SCID-IL2R)
gamma (null) (additionally lack natural killer (NK)-cell
activity) mice (male, 10e12 weeks, The Jackson Laboratory,
USA) were used for in vivo experiments. Experiments were
approvedby thecommitteeonanimalwelfareofour institute.
Surgical procedure to induce hind limb ischaemia
and injection of cells
Before surgery, mice were anaesthetised with intraperito-
neal (i.p.) injection of a combination of Midazolam
(5 mg kg1, Roche), Medetomidine (0.5 mg/kg1 Orion) and
fentanyl (0.05 mg kg1, Janssen). The effect of transfusion
of human monocytes was tested in two models of hind limb
ischaemia: a total excision model and a double electro-
coagulation model.17For unilateral total excision of the femoral artery, liga-
tures were placed proximal (inguinal ligament) and distal
(popliteal artery). After dissecting all side branches, the
whole artery was removed after cutting the femoral artery
between the ligatures. For the double coagulation model,
both common iliac artery and femoral artery were unilat-
eral electro-coagulated. First, an electro-coagulation of
the common iliac artery was performed, and, directly
afterwards, an electro-coagulation of the femoral artery.
After surgery, the skin was closed with Ethilon 6.0 sutures.
Twenty-four hours after surgery, mice were intravenously
(I.V.) injected into the tail vein with PBS, unstimulated
control or pre-stimulated monocytes.
Laser Doppler perfusion imaging
Blood flow was measured before ischaemia induction,
immediately after ischaemia induction and 3, 7, 14, 21 and
28 days after surgery in the ischaemic and non-ischaemic
paws, using laser Doppler perfusion imaging (LDPI) (Moor
Instruments). Perfusion was expressed as a ratio of the
ischaemic to non-ischaemic limb, as described previously.18
Histological analysis
Animals were sacrificed 28 days after ischaemia induction
and calf and adductor muscles (from ischaemic and non-
ischaemic paw) were removed and fixed with 4% formal-
dehyde and paraffin embedded. Serial 5-mm cross-sections
were generated. Sections were re-hydrated and endoge-
nous peroxidase activity was blocked for 20 min in meth-
anol containing 0.3% hydrogen peroxide. Capillaries and
collaterals were visualised using antibodies recognising
CD31 on endothelial cells or a-smooth muscle actin (SMA) in
smooth muscle cells, respectively.
For CD31 labelling, sections were pre-incubated with
trypsin (30 min per 37 C), incubated overnight with
primary antibody (BD Biosciences) followed by a biotin-
conjugated secondary antibody (AbCam). The reaction was
enhanced by tyramine amplification and the avidinebiotin
horseradish peroxidase (HRP) system (DakoCytomation) and
visualised by NovaRED (Vector Laboratories).
For SMA labelling, tissue sectionswere incubated overnight
with anti-aSMA (Dako) without antigen retrieval. Labelling
was followed by an HRP-conjugated secondary antibody
(Dako). Anti-human CD45 was used to identify human cells in
frozen tissue sections fixed with ice-cold acetone. Labelling
was visualised using the above described HRP-labelling
procedure. All sections were counterstained with haematox-
ylin. Isotype control antibodies were used as controls. Quan-
tification of labelled tissue sections was performed using
ImageJ (9 sections per mouse were analysed to obtain the
mean per animal, 10 animals per group were measured).
Distribution of human primary cells
Blood was harvested and single cell suspensions were made
of the spleen, liver and the non-ischaemic femur at 24 h
(nZ 2), 48 h (nZ 3) or 7 days (nZ 3) after transplantation
with pre-stimulated monocytes. The adductor and calf
muscles of both paws were frozen and cross-sectioned for
Figure 1 Spindle-shaped monocyte clusters are formed from classical CD16 and non-classical CD16þ monocyte subsets. A. Total
CD14þ-monocytes were cultured in Endocult medium without (upper row) or pre-stimulated with soluble T-cell-derived factors
(lower row) and imaged after 24 h (left), 48 h (middle) or 5 days (right). Magnification 100. B. Flowcytometry was used to
determine the cell surface expression of CD14 and CD16 on naı¨ve uncultured monocytes (left dot plot), unstimulated monocytes
cultured for 48 h (middle) or pre-stimulated monocytes cultured for 48 h (right dot plot). C. The histograms depict the number of
clusters formed by monocyte subsets that were sorted based on their CD14 and CD16 expression using regions R1eR3 as indicated in
Figure 1B. Sorted cells were cultured for 5 days in Endocult medium supplemented with soluble T-cell-derived factors.
A representative donor out of 2 different donors is shown.
Figure 2 Pre-stimulated CD14þ-monocytes do not develop into endothelial-like cells and are phenotypically distinct from
classical macrophages and DC. A. Histograms show cell surface expression as determined by flowcytometry of the indicated
haematopoietic or endothelial cell-associated markers in black lines and isotype controls as filled grey histograms of unstimulated
control monocytes or pre-stimulated monocytes cultured for 48 h. B. Histograms show cell surface expression as determined by
flowcytometry of the indicated co-stimulatory or subset-specific markers in black lines and isotype controls as filled grey histo-
grams of pre-stimulated, M-CSF-stimulated or GM-CSFþIL-4-stimulated monocytes that were cultured for 48 h. A representative
donor/culture is shown. Results were confirmed in at least 3 different donors.
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Pre-stimulated Monocytes Promote Revascularisation 423immunohistochemistry. Human cells were visualised using
flowcytometry with a directly conjugated human-specific
anti-CD45 antibody (BectoneDickinson).
Statistical analysis
Results are expressed as mean  SEM (standard error of the
mean). For in vivo and ex vivo experiments, comparisons
between means were performed using a one-way analysis
of variance (ANOVA) test. For in vitro protein measure-
ments, comparisons between means were performed using
a paired t-test. P-values <0.05 were considered statisti-
cally significant. Calculations were performed in Statistical
Package for Social Sciences (SPSS) 16.0.
Results
Spindle-shaped monocyte clusters are formed from
both classical and non-classical monocyte subsets
Typical spindle-shaped clusters formed upon culture of
CD14þ-monocytes with soluble T-cell-derived factors (Fig. 1
(A), lower row), but not when cultured without soluble
T-cell-derived factors (Fig. 1(A), upper row) or upon addition
of soluble T-cell-derived factors of unstimulated CD4þ-T-cells
(not shown). Upon culture of total CD14þ-selected cells,
control and pre-stimulatedmonocytes both express CD14 and
CD16, similar to uncultured non-classical monocytes (Fig. 1
(B)). We therefore questioned whether cluster formation
was related to a distinct monocyte subset. Using fluorescence
activated cell sorting (FACS)weseparatedunculturedCD16neg
(R1), CD16med (R2) and CD16hi (R3) human CD14þ-monocyte
subsets and observed that all subsets are able to form spindle-
shaped clusters upon pre-stimulation (Fig. 1(C)).
Pre-stimulated monocytes do not develop into
endothelial-like cells and are phenotypically
distinct from classical macrophages and DCs
Considering the controversy regarding the monocyte-
related origin of EPC, we examined whether pre-stimulated
CD14þ-monocytes express endothelial cell (EC)-specific
markers upon culture. Both control and pre-stimulated
monocytes retain cell surface expression of the leucocyte-
specific b2-integrin CD11b and CD45 at the cell surface and
show comparable expression of the b1-integrins CD49f and
CD49d or the shared haematopoietic/EC marker CD31
(Fig. 2(A)). Expression of the haematopoietic stem cell/EC-
specific CD34 was not observed upon culture.
T-cell-derived soluble factors can induce differentiation
of monocytes into immature DCs and also increase expres-
sion of the co-stimulatory molecules CD40, CD83 and
CD86.19 To investigate whether our culture procedure
induced a distinct differentiation programme, we
compared cell surface expression of co-stimulatory and
subset-specific molecules with that of classical monocyte
progeny such as macrophages or DCs.
No differences in the surface expression levels of the
above-mentioned co-stimulatory molecules were observed
between pre-stimulated and GM-CSF þ IL-4-cultured
monocytes (Fig. 2(B)) whereas expression levels of thetypical macrophage marker CD115 and the DCmarker CD209
(DC-Sign) were considerably lower on pre-stimulated
monocytes as compared with M-CSF-generated macro-
phages or GM-CSF þ IL-4-generated DCs (Fig. 2(B)). These
differences suggest an alternative route of differentiation
via pre-stimulation with T-cell-derived soluble factors.
Pre-stimulation of total CD14D-monocytes induces
the capacity to improve blood flow recovery in vivo
Directly after total excision of the femoral artery, blood flow
in the treated hind limb decreased to less than 10% of the
blood flow of the untreated hind limb (Fig. 3(A)). Blood flow
recovery progressed gradually in all groups (n Z 10 per
group). Nude C57Bl6 mice transfused with pre-stimulated
monocytes showed significantly improved blood flow
recovery from day 7 until day 21 after ischaemia as compared
with mice transfused with PBS or unstimulated control
monocytes (Fig. 3(A)). Fourteen days after surgery, restora-
tion of blood flow was complete in mice transfused with pre-
stimulatedmonocytes, whereas only 70% restoration of blood
flow was observed in the treated hind limb of control mice.
Importantly, transfusion of unstimulated control monocytes
did not have any beneficial effect on blood flow recovery.
Increase in collateral and capillary density in post-
ischaemic skeletal muscle of mice treated with pre-
stimulated monocytes
Mice treated with pre-stimulated monocytes showed
a significantly higher number of a-SMA-expressing collat-
erals in the post-ischaemic adductor muscle as compared
with controls (Fig. 3(B)). Furthermore, significantly larger
collaterals were observed in the adductor muscle of mice
transfused with pre-stimulated monocytes as compared
with controls (Fig. 3(B)). The collateral density or cross-
sectional surface (diameter) of SMA-expressing collaterals
of the non-operated hind limb did not show any differences
between groups (data not shown). In addition, transfusion
with pre-stimulated monocytes significantly increased the
CD31þ-capillary density of the post-ischaemic calf muscles
of mice as compared with controls (Fig. 3(C)). Again,
analyses of capillary density of the non-operated paw did
not show differences between the groups (data not shown).
To visualise collateral growth in the post-ischaemic hind
limb, angiographs were made 14 days after hind limb
ischaemia induction. Solid collaterals were observed in the
angiographs of post-ischaemic adductor muscles of mice
transfused with pre-stimulated monocytes (Fig. 3(D)),
confirming the results of the SMA staining.
Improved blood flow recovery after transfusion of
pre-stimulated monocytes in a double electro-
coagulation hind limb ischaemia mouse model
To confirm general application of the above-described
findings, we injected pre-stimulated CD14þ-monocytes in
NOD-SCID IL2R gamma (null) mice after double electro-
coagulation of both the femoral artery and the iliac artery.
Again, transfusion with pre-stimulated monocytes signifi-
cantly improved blood flow recovery after ischaemia as
424 A.A. Hellingman et al.
Figure 4 Pre-stimulated CD14þ-monocytes improve blood flow restoration after double electro-coagulation. The graphs depicts
the mean  SEM of blood flow restoration in hind limbs of NOD-SCID-IL2R gamma (null) mice after transfusion with PBS (n Z 10),
unstimulated control monocytes (nZ 6) or pre-stimulated monocytes (nZ 4). )P < 0.05. Images on the right depict representative
LDPI images of paws of mice transfused with PBS (upper), unstimulated monocytes (middle) or pre-stimulated monocytes (lower) 14
days after induction of hind limb ischaemia. Blood flow was monitored for 4 weeks and expressed as ratio between the operated
and non-operated limb measured before and after surgery at day 3, 7, 14, 21 and 28. The residual blood flow was determined by
measuring the blood flow directly after surgery. )P < 0.05.
Pre-stimulated Monocytes Promote Revascularisation 425compared with PBS, 21 and 28 days after ischaemia
induction (Fig. 4).
Few human cells were found in the post-ischaemic
muscle tissue
The distribution of pre-stimulated monocytes was assessed in
blood, spleen, liver and BM after 24 h, 48 h or 7 days using
flowcytometry in combination with an a-humanCD45-specific
antibody.Humancellswerenot observed inanyof the tissues/
time-points examined by FACS analysis of the tissue extracts
(data not shown). However, human cells were observed upon
total sectioning of the ischaemic adductor tissue after 24 h
(Fig. 5(A)), indicating that humanmonocytes can be recruited
to the murine muscle tissue upon ischaemia induction.Figure 3 Transfusion of pre-stimulated CD14þ-monocytes impro
artery. A. The graph depicts the mean  SEM of blood flow restorat
(nZ 10), unstimulated control monocytes (nZ 10) (control) or pre-
weeks and expressed as ratio between the operated and non-opera
and 28. The residual blood flow was determined by measuring the b
depict representative LDPI images of paws of mice transfused wit
lated monocytes (lower) at 14 days after induction of hind limb is
collaterals (left) or mean  SEM of the collateral surface (right) in
muscle actin (SMA) labelling. )P < 0.05, ))P < 0.01. Represen
transfusion with PBS (left), unstimulated monocytes (middle) and
histogram depicts mean  SEM of the number of capillaries in the p
CD31 labelling (9 sections per muscle were analysed of 10 anima
photographs of CD31-labelling are shown 28 days after transfusio
stimulated monocytes (right). Magnification 100. D. Representativ
of post-ischaemic paws transfused with PBS (left), unstimulated
contrast to mice transfused with PBS or non-stimulated monocytes
monocytes showed typical cork-screw like collaterals as is indicatePre-stimulated monocytes produce a wide variety
of pro-angio-/arteriogenic factors
We next examined whether pre-stimulated monocytes
produce pro-angio- and/or pro-arteriogenic growth factors.
Increased levels of platelet-derived growth factor (PDGF)-
BB, VEGF, IL-6, IL-8, IL-10 and tumour necrosis factor (TNF)-
a were observed in medium conditioned by pre-stimulated
monocytes as compared with unstimulated control mono-
cytes after 24, 48 and 72 h. Significant increases in
expression levels were found after 72 h for granulocyte-
CSF, IL-4, IL-13, IL-17 and interferon (IFN)g, whereas the
levels of fibroblast growth factor(FGF), GM-CSF and
IL-12p70 did not differ between media conditioned by
unstimulated or pre-stimulated monocytes (Fig. 5(B)).ves blood flow restoration after total excision of the femoral
ion in hind limb of nude C57Bl6 mice after transfusion with PBS
stimulated monocytes (nZ 10). Blood flow was monitored for 4
ted limb measured before and after surgery at day 3, 7, 14, 21
lood flow directly after surgery. )P < 0.05. Images on the right
h PBS (upper), unstimulated monocytes (middle) or pre-stimu-
chaemia. B. Histograms depict mean  SEM of the number of
the post-ischaemic adductor muscle as quantified by smooth
tative photographs of SMA-labelling are shown 28 days after
pre-stimulated monocytes (right). Magnification 100. C. The
ost-ischaemic calf muscle as quantified by anti-mouse-specific
ls/treatment group). )P < 0.05, ))P < 0.01. Representative
n with PBS (left), unstimulated monocytes (middle) and pre-
e angiographs were made 14 days after the surgical procedure
monocytes (middle) and pre-stimulated monocytes (right). In
, the adductor muscle of mice transfused with pre-stimulated
d with the black arrow.
Figure 5 Pre-stimulated CD14þ-monocytes produce various pro-angio-/arteriogenic factors. A. Images show isotype control (left)
and anti-humanCD45-specific (right) labelling of the ischeamic adductor muscle, 24 h upon transfusion of pre-stimulated human
monocytes. Magnification 400. B. Histograms show the mean  SEM (nZ 3) of indicated growth factors and cytokines determined
in media conditioned for 24, 48 or 72 h by unstimulated control or pre-stimulated monocytes after the removal of initial culture
media used for stimulation (48 h) and vigorous washing with PBS. )P < 0.05, ))P < 0.01.
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There is ample evidence that monocytes play a crucial role
in neovascularisation, and have the potential to augment
collateral artery growth. For that reason, transfusion of
CD14þ-monocytes has been highlighted as cell therapy that
promotes revascularisation in adults. Previous studies
showed that proper stimulation of monocytes is critical to
exploit this capacity.9,10 In the present study, we show that
pre-stimulation of total CD14þ-monocytes with activated
CD4þ-T-cell-derived soluble factors enhanced their
capacity to promote revascularisation and significantly
improved restoration of blood flow recovery after hind limb
ischaemia as compared with untreated mice or mice
transfused with unstimulated monocytes.
Monocyte transfusion was first examined in a total exci-
sion model using nude C57Bl6 mice and additionally tested in
a double electro-coagulation model using NOD-SCID-IL2R
gamma (null) mice. Total excision of the femoral artery
disrupts all connections to the pre-existing collateral bed. To
form functional collaterals in this model, the pre-existingvessels need not only enlarge their diameter (arterio-
genesis), the disrupted connections also require repair and
sprouting of new capillaries (angiogenesis). By contrast, all
side branches and pre-existing connections to the vascula-
ture are kept intact upon double electro-coagulation of the
vascular tree in the second model, which mimics the clinical
situation of multi-level occlusions in PAD at best. Pre-stim-
ulation ofmonocytes significantly improved revascularisation
in both models, which emphasises the capacity of pre-stim-
ulated monocytes to improve vascular regeneration.
In addition to LDPI monitoring, immunohistochemical
analysis was used to examine neovascularisation at the tissue
level. In accordance with the LDPI data, SMA staining of the
post-ischaemic adductor muscle showed an increase in
collateral density and collateral diameter upon transfusion of
pre-stimulated monocytes as compared with unstimulated
monocytes or PBS. Moreover, a three-fold higher CD31þ-
capillarydensitywasobservedafter pre-stimulatedmonocyte
transfusion as comparedwith controls,which underscores the
capacityofpre-stimulatedmonocytes to support botharterio-
as well as angiogenesis in the total excision model.
Pre-stimulated Monocytes Promote Revascularisation 427As sentinels of the innate immune system, monocytes
efficiently communicate with T-lymphocytes. T-lympho-
cytes are immune cells that belong to the adaptive immune
system but they also play an evident role in adult vascular
repair.11,12 Hampered monocyteeT-cell interactions, as
exemplified by the reduced formation of CFUeHill clusters,
appear to be correlated with cardiovascular disease.14
Although the extrapolation to in vivo mechanisms is still
unresolved, CFUeHill cluster formation is regarded as
a marker of vascular regeneration. CFUeHill cluster
formation is efficiently mimicked by purified monocytes
that are stimulated by soluble T-cell-derived factors.13 In
this study, we show the effectiveness of this pre-stimula-
tion to direct monocyte differentiation in a pro-angio-/
arteriogenic-supporting pathway. Cell surface expression
profiles of lineage- and subset-specific markers indicate
that these pro-angio-/arteriogenic monocytes do not
develop into EPC or EC-like cells. Moreover, they pheno-
typically differ from macrophages and DCs.
Upon I.V. infusion, the pre-stimulated monocytes were
detected in the ischaemic adductor muscle, but did not
incorporate into the vessel wall. Overall, few human cells
were found, suggesting that they are present transiently
or act in a more systemic manner, most likely via the
release of paracrine factors. In support of this idea, we
show that pre-stimulated monocytes produce a wide
variety of growth factors and cytokines that are known to
promote neovascularisation,20e22 such as VEGF, PDGF-BB,
TNFa, IL-1b, IL-4 and IL-13. Other factors such as G-CSF
and IL-8 may additionally favour neovascularisation indi-
rectly by stimulating the mobilisation of leucocytes and
EPC from the BM. Fortunately, no increase was observed
of the pro-inflammatory cytokine IL-12. However, the
increased IFNg production warrants some precaution:
IFNg positively affects myeloid cell proliferation, but has
been shown to directly induce arteriosclerosis of the
vessel wall.23
Although effective, in the current form, this approach is not
yet suitable for clinical use. To be able to replace the alloge-
neic T-cell-derived factors, we will need to delineate those
factors that drive pro-angio-/arteriogenic monocyte differen-
tiation. This additionally may open up vistas to pharmacolog-
ical solutions that support pro-angio-/arteriogenic monocyte
differentiation in vivo. Furthermore, in the hind limb
ischaemia models used, it is presently not clear by which
mechanism the transfused monocytes contribute to the
improved neovascularisation. The involvement of transfused
cultured monocytes might differ from that of endogenous
unculturedmonocytes thatnormallycirculate in theperipheral
blood. To optimise the current strategy, further studies will be
required to identify the exact role of the transfusedmonocyte.
Overall, our results support a beneficial role for pre-
stimulated monocytes in vascular regeneration and render
this pro-angio-/arteriogenic monocyte an interesting
candidate for regenerative cell therapy that promotes
revascularisation in patients with PAD.
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